​

Assembly Biosciences (ASMB) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChart

ASMB Stock Forecast

Assembly Biosciences (ASMB) stock forecast, based on 11 Wall Street analysts, predicts a 12-month average price target of $39.00, with a high of $40.00 and a low of $38.00. This represents a 42.65% increase from the last price of $27.34.

- $8 $16 $24 $32 $40 High: $40 Avg: $39 Low: $38 Last Closed Price: $27.34

ASMB Stock Rating

Assembly Biosciences stock's rating consensus is Buy, based on 11 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 6 Buy (54.55%), 5 Hold (45.45%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 11 0 5 6 Strong Sell Sell Hold Buy Strong Buy

ASMB Price Target Upside V Benchmarks

TypeNameUpside
StockAssembly Biosciences42.65%
SectorHealthcare Stocks 15.45%
IndustryBiotech Stocks 41.48%

Price Target Trends

1M3M12M
# Anlaysts-12
Avg Price Target-$40.00$39.00
Last Closing Price$27.34$27.34$27.34
Upside/Downside-46.31%42.65%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jan, 26-4---4
Dec, 25-4---4
Nov, 2523---5
Oct, 2523---5
Sep, 2513---4
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Nov 20, 2025Salim SyedMizuho Securities$40.00$39.002.56%46.31%
Sep 24, 2025Roy BuchananJMP Securities$38.00$25.9046.72%38.99%
Sep 24, 2024Salim SyedMizuho Securities$36.00$16.26121.40%31.68%
Sep 20, 2024Dennis DingJefferies$35.00$18.5089.19%28.02%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Dec 22, 2025H.C. WainwrightBuyBuyhold
Sep 24, 2025CitigroupOutperforminitialise
Sep 08, 2025GuggenheimBuyBuyhold
Mar 25, 2025GuggenheimBuyinitialise
Sep 24, 2024H.C. WainwrightNeutralNeutralhold
Sep 20, 2024JefferiesBuyupgrade

Financial Forecast

EPS Forecast

$-30 $-24 $-18 $-12 $-6 $0 Dec 21 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-2.79$-13.38$-6.69----
Avg Forecast$-25.20$-14.22$-6.76$-7.37$-6.24$-9.74$-8.01
High Forecast$-20.34$-13.75$-6.53$-6.99$-5.91$-9.41$-7.74
Low Forecast$-28.70$-14.69$-6.98$-7.74$-6.56$-10.06$-8.28
Surprise %-88.93%-5.91%-1.04%----

Revenue Forecast

$0 $70M $140M $210M $280M $350M Dec 21 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$6.25M$7.16M-----
Avg Forecast$7.41M$7.16M$24.60M$32.65M$105.00M$221.00M$299.00M
High Forecast$8.21M$7.35M$25.23M$33.49M$107.69M$226.67M$306.67M
Low Forecast$6.31M$6.98M$23.97M$31.81M$102.31M$215.33M$291.33M
Surprise %-15.63%------

Net Income Forecast

$-150M $-120M $-90M $-60M $-30M $0 Dec 21 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-129.85M$-61.23M$-40.18M----
Avg Forecast$-115.35M$-65.09M$-30.92M$-33.71M$-28.54M$-44.56M$-36.66M
High Forecast$-93.11M$-62.92M$-29.89M$-32.02M$-27.05M$-43.07M$-35.44M
Low Forecast$-131.39M$-67.26M$-31.95M$-35.41M$-30.03M$-46.05M$-37.89M
Surprise %12.57%-5.93%29.94%----

ASMB Forecast FAQ

Is Assembly Biosciences stock a buy?

Assembly Biosciences stock has a consensus rating of Buy, based on 11 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 6 Buy, 5 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Assembly Biosciences is a favorable investment for most analysts.

What is Assembly Biosciences's price target?

Assembly Biosciences's price target, set by 11 Wall Street analysts, averages $39 over the next 12 months. The price target range spans from $38 at the low end to $40 at the high end, suggesting a potential 42.65% change from the previous closing price of $27.34.

How does Assembly Biosciences stock forecast compare to its benchmarks?

Assembly Biosciences's stock forecast shows a 42.65% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the biotech stocks industry (41.48%).

What is the breakdown of analyst ratings for Assembly Biosciences over the past three months?

  • January 2026: 0% Strong Buy, 100.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • December 2025: 0% Strong Buy, 100.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • November 2025: 40.00% Strong Buy, 60.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is Assembly Biosciences’s EPS forecast?

Assembly Biosciences's average annual EPS forecast for its fiscal year ending in December 2025 is $-7.37, marking a 10.16% increase from the reported $-6.69 in 2024. Estimates for the following years are $-6.24 in 2026, $-9.74 in 2027, and $-8.01 in 2028.

What is Assembly Biosciences’s revenue forecast?

Assembly Biosciences's average annual revenue forecast for its fiscal year ending in December 2025 is $32.65M, reflecting a 0% decrease from the reported $0 in 2024. The forecast for 2026 is $105M, followed by $221M for 2027, and $299M for 2028.

What is Assembly Biosciences’s net income forecast?

Assembly Biosciences's net income forecast for the fiscal year ending in December 2025 stands at $-33.713M, representing a -16.09% decrease from the reported $-40.177M in 2024. Projections indicate $-28.54M in 2026, $-44.561M in 2027, and $-36.665M in 2028.